Last Price
71.04
Today's Change
-1.87 (2.56%)
Day's Change
70.19 - 73.22
Trading Volume
1,723,418
Market Cap
12 Billion
Shares Outstanding
171 Million
Avg Volume
2,535,803
Avg Price (50 Days)
73.72
Avg Price (200 Days)
42.14
PE Ratio
-13.13
EPS
-5.41
Earnings Announcement
24-Oct-2024
Previous Close
72.91
Open
72.72
Day's Range
70.19 - 73.22
Year Range
21.92 - 80.53
Trading Volume
1,723,418
1 Day Change
-2.56%
5 Day Change
-8.39%
1 Month Change
0.07%
3 Month Change
24.96%
6 Month Change
155.82%
Ytd Change
137.27%
1 Year Change
167.17%
3 Year Change
152.45%
5 Year Change
295.11%
10 Year Change
383.59%
Max Change
-56.95%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.